WHWK Whitehawk Therapeutics, Inc.
$4.11▲ +0.98%
Healthcare
Other
After hours
$4.11▲ +0.00%
Sep 11, 7:30 PM ET
Volume 283.5K
Avg Volume (10D) 309.5K
Key Metrics & Fundamentals
Market Cap
$234.31M
P/E Ratio
–
Div Yield
–%
52W Range
1.80 - 5.50
% vs 50 MA
-4.01%
% vs 200 MA
12.54%
RSI-14
38.8
MACD Histogram
-0.1000
Beta (1Y vs SPY)
1.59
Free Cash Flow
-$14.53M
Gross Rev
$0
Gross Profit
$0
EBITDA
-$18.10M
COGS
$0
Operating Exp
$18.11M
Operating Income
-$18.11M
EBIT
-$18.11M
Pretax Income
-$16.64M
Net Income
-$16.64M
EPS (Diluted)
-0.20
Price & Volume History
Loading chart…
Recent News
Whitehawk Therapeutics Presents Real-World Analyses Supporting PTK7 as a Durable ADC Target in EGFR Wild-Type Non-Small Cell Lung Cancer at WCLC 2026
PR Newswire · Sep 14, 2026 1:30 AM
Whitehawk Therapeutics Appoints Vijay Iyengar, MD, to Board of Directors
PR Newswire · Sep 10, 2026 8:05 PM
Whitehawk Therapeutics to Participate in Upcoming Investor Conferences
PR Newswire · Sep 2, 2026 12:00 PM
What Makes Whitehawk Therapeutics, Inc. (WHWK) a Strong Momentum Stock: Buy Now?
Zacks · Aug 28, 2026 4:00 PM
Wall Street Analysts Predict a 47.64% Upside in Whitehawk Therapeutics, Inc. (WHWK): Here's What You Should Know
Zacks · Aug 26, 2026 1:55 PM
Akari Therapeutics Reports Second Quarter 2026 Financial Results and Highlights Progress of AKTX-101 Towards Phase 1 and Strategic Collaboration for Its ADC Payload Platform
GlobeNewswire · Aug 13, 2026 8:15 PM
Whitehawk Therapeutics Reports Second Quarter 2026 Financial Results and Recent Highlights
PR Newswire · Aug 6, 2026 12:00 PM
Akari Therapeutics Releases CEO Corner Highlighting Strategic WhiteHawk Collaboration and the Expanding Opportunity for Dual-Payload ADC Innovation
GlobeNewswire · Aug 4, 2026 12:50 PM
Akari Therapeutics CEO Explains Why Growing Industry Demand for Next-Generation ADC Payloads Positions the Company at the Center of a Major Oncology Opportunity
GlobeNewswire · Jul 22, 2026 12:40 PM
Akari Therapeutics, Whitehawk Therapeutics Collaborate to Develop ADC Cancer Treatments
MT Newswires · Jul 21, 2026 12:24 PM
Financial Overview - Income Statement
Quarterly
Mar 2025
See WHWK's money flow as a full page
Social Sentiment
No Reddit posts found for WHWK.
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.